Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 68 papers

Statins: Old drugs as new therapy for liver diseases?

Pose E, Trebicka J, Mookerjee RP, Angeli P, Ginès P.

J Hepatol 2019, 70(1): 194–202

DOI: 10.1016/j.jhep.2018.07.019

Management of acute liver failure – Clinical guideline from the Catalan Society of Digestology

Escorsell À, Castellote J, Sánchez-Delgado J, Charco R, Crespo G, Fernández J.

Gastroenterol Hepatol 2019, 42(1): 51–64

DOI: 10.1016/j.gastrohep.2018.07.013

Acute-on-chronic liver failure: Getting ready for prime time?

Bajaj JS, Moreau R, Kamath PS, Vargas HE, Arroyo V, Reddy KR, Szabo G, Tandon P, Olson J, Karvellas C, Gustot T, Lai JC, Wong F.

Hepatology 2018, 68(4): 1621–1632

DOI: 10.1002/hep.30056

Systemic inflammation and acute-on-chronic liver failure: Too much, not enough

Laleman W, Claria J, Van der Merwe S, Moreau R, Trebicka J.

Can J Gastroenterol Hepatol 2018, 2018: 1027152

DOI: 10.1155/2018/1027152

Gut–liver axis links portal hypertension to acute-on-chronic liver failure

Trebicka J, Reiberger T, Laleman W.

Visc Med 2018, 34(4): 270–275

DOI: 10.1159/000490262

Covered transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: Looking for the right patient and the right time

Senzolo M, Thabut D, Trebicka J.

EMJ Hepatol 2018, 6(Suppl 2): 2 –11

DOI: 10.33590/emjhepatol/10311962

Managing portal hypertension in patients with liver cirrhosis

Sauerbruch T, Schierwagen R, Trebicka J.

F1000Res 2018 , 7: F1000 Faculty Rev-533

DOI: 10.12688/f1000research.13943.1

“Tipping” extracellular matrix remodeling towards regression of liver fibrosis: Novel concepts

Magdaleno F, Schierwagen R, Uschner FE, Trebicka J.

Minerva Gastroenterol Dietol 2018, 64(1): 51–61

DOI: 10.23736/S1121-421X.17.02442-4

Does transjugular intrahepatic portosystemic shunt stent differentially improve survival in a subset of cirrhotic patients?

Trebicka J.

Semin Liver Dis 2018, 38(1): 87–96

DOI: 10.1055/s-0038-1627457

Pro-resolving actions of SPM in adipose tissue biology

Clària J, López-Vicario C, Rius B, Titos E.

Mol Aspects Med 2017, 58: 83–92

DOI: 10.1016/j.mam.2017.03.004

Registered office

European Foundation for the Study of
Chronic Liver Failure
Travessera de Gràcia 11, 7th floor
08021 Barcelona, Spain

Legal

Contact us

T +34 93 227 14 00
E efclif@efclif.com

© European Foundation for the Study of Chronic Liver Failure 2024